Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis

Fig. 4

Number of girls needed to be vaccinated with the first and second dose to avert one additional cervical cancer case by income group. The lines represent the median projections of the 10 model-country settings: the HSA model in black, HPV-ADVISE model-country pairs in red, and the Harvard model-country pairs in blue. Health outcomes were discounted at 3% (A–D) and 0% (E–H)

Back to article page